Form 13-F position report

SONNET BIOTHERAPEUTC HLDNG

Reported by GEODE CAPITAL MANAGEMENT LLC

SONN CUSIP 83548R402 Manager CIK 0001214717

Reported 0 shares, down 61,840 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2025
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 4 Through Q4 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-03-31 33238
2025-06-30 30865
2025-09-30 283226
2025-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for SONNET BIOTHERAPEUTC HLDNG held by GEODE CAPITAL MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 0 -61,840 (-100.0%) 0 $0 2026-02-09
Q3 2025 Added 61,840 +36,948 (148.4%) < 0.01% $283,226 2025-11-12
Q2 2025 Added 24,892 +87 (0.4%) < 0.01% $30,865 2025-08-08
Q1 2025 New 24,805 +24,805 (0.0%) < 0.01% $33,238 2025-05-13

Who else reported the position

28 managers reported SONNET BIOTHERAPEUTC HLDNG for Q4 2025.

Managers reporting SONNET BIOTHERAPEUTC HLDNG in Q4 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Formidable Asset Management LLC New 37,185 +37,185 0.02% $170,307 1 qtr
TWO SIGMA INVESTMENTS LP Reduced 0 -14,972 0 $0 2 qtrs
NORTHERN TRUST CORPORATION Reduced 0 -17,860 0 $0 2 qtrs
BIT Capital GmbH Reduced 0 -48,358 0 $0 2 qtrs
ADVISOR GROUP HOLDINGS INC Reduced 0 -175 0 $0 2 qtrs
Golden State Wealth Management LLC Reduced 0 -202 0 $0 2 qtrs
BlackRock Inc Reduced 0 -21,940 0 $0 6 qtrs
UBS Group AG Reduced 0 -277 0 $0 5 qtrs
The Goldman Sachs Group Inc Reduced 0 -55,134 0 $0 2 qtrs
JPMorgan Chase & Co Reduced 0 -7,537 0 $0 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2025
Filed
February 09, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.